Oberon AIM VCT
Applications closed
Important information - Venture Capital Trusts (VCTs) invest in small, early-stage, unlisted companies and are considered high-risk investments. It’s difficult to access your money in the short term and their value can go down as well as up so you could get back less than you put in. VCTs are long-term investments and should only be a consideration for experienced investors with larger portfolios. We suggest they form a small part of a diversified portfolio. This isn’t personal advice, if you’re unsure if VCTs are right for you, please consider taking advice. Tax rules can change, and their benefits depend on your individual circumstances.
About Oberon AIM VCT
Oberon AIM VCT is a strategic relaunch of the New Century AIM VCT 2, aimed at rejuvenating and repositioning the trust to enhance its appeal as a tax-efficient investment vehicle, focused on AIM-listed shares. The manager believes that although there’s been an extended period of underperformance in small-cap and AIM markets which has been challenging, history suggests they could now be on the brink of a market rebound.
Key facts
Launched in April 2007
Annual dividend target of 5%. But dividends are not guaranteed
Raising £5mn with a £3.4mn over-allotment facility
As at 31 December 2024 the VCT held £1.4mn in assets under administration
Before applying you should read the prospectus, supplementary prospectus and key information document. This contains helpful information about how the VCT works and is invested, but also will help you understand any further risks you should be aware of.
Ready to Invest?
Make sure you’ve read these key documents. They cover in more detail the risks and investment strategy of this VCT.
Example companies held by Oberon AIM VCT
Renalytix is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease. The company's flagship product, KidneyIntelIX, is designed to enhance kidney disease diagnosis and prognosis, manage transplants, improve clinical care, and aid in patient stratification for drug clinical trials and drug target discovery.
A life science company dedicated to skin health, this firm targets five specific sectors: cosmetic skincare, food supplements for skin conditions, medical skincare, and infection control in both home and hospital environments. The company has developed multiple applications for active skincare to treat conditions such as eczema, rosacea, psoriasis, acne, provide UV protection, and aid in wound healing.
Audioboom stands as a global leader in podcasting, boasting 100 million downloads each month by 38 million unique listeners worldwide. The platform operates on an international scale, maintaining global partnerships across North America, Europe, Asia, and Australia. Audioboom distributes its content through a variety of channels including Apple Podcasts, YouTube, Pandora, Amazon Music, Google Podcasts, iHeartRadio, and social media platforms such as Facebook and Twitter, as well as through partners' own websites and mobile apps.
To see more detail on how the VCT invests, check the VCT prospectus, supplementary prospectus and brochure.
Past Performance
You can view the past performance data of this VCT on our factsheet. You’ll need to return to this page to place a deal.
Costs and charges
| VCT manager initial charge: | 2.5% |
| HL saving on the initial charge: | 0% |
| Net initial charge | 2.5% |
| Ongoing charge | 6.3% |
If you wish to sell your VCT, telephone rates of commission will apply (1%, minimum £20, maximum £50).
Other incidental charges for buying and selling investments may apply. Details on this are available in the prospectus and key information document.
Full breakdown of charges
The following charges are based on an investment of £10,000 within a Fund and Share Account over 5 years assuming a 5% growth rate. We’ve used the initial charge including the HL saving, but no further discounts like early bird or existing investor discounts have been applied. The annual rebate is also not included.
Holders should also get income from the VCT, on which there's no charge from HL and so isn't included in these figures. The income you’ll receive isn't guaranteed and you could get back less than you invest.
| Management charge | £0.00 |
| Entry dealing charge | £0.00 |
| Exit dealing charges | £50.00 |
| Stamp duty (N/A) | £0.00 |
| Net initial charge (2.5%) | £250.00 |
| Ongoing charge (6.3%) | £2,906.73 |
| Transaction costs | £0.00 |
| Incidental charges | £0.00 |
| Total charges over 5 years | £3,206.73 |
| Average annual charge | 6.78% |
| Illustrative 5-year value | £9,103.89 |
| Illustrative 5-year value with no charges applied | £12,762.82 |
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Total | |
|---|---|---|---|---|---|---|
| HL Charges | £0.00 | £0.00 | £0.00 | £0.00 | £50.00 | £50.00 |
| Management charge | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Entry dealing charge | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Exit dealing charge | £0.00 | £0.00 | £0.00 | £0.00 | £50.00 | £50.00 |
| Investment charges | £846.16 | £588.69 | £581.30 | £574.02 | £566.56 | £3,156.73 |
| Stamp duty (N/A) | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Net initial charge (2.5%) | £250.00 | £0.00 | £0.00 | £0.00 | £0.00 | £250.00 |
| Ongoing charge (6.3%) | £596.16 | £588.69 | £581.30 | £574.02 | £566.56 | £2,906.73 |
| Transaction costs | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Incidental charges | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Total charges over 5 years | £846.16 | £588.69 | £581.30 | £574.02 | £616.56 | £3,206.73 |
| Average annual charge | 8.74% | 6.16% | 6.16% | 6.16% | 6.70% | 6.78% |
| Illustrative 5-year value | £9,627.75 | £9,507.04 | £9,387.83 | £9,270.13 | £9,103.89 | £9,103.89 |
| Illustrative 5-year value with no charges applied | £10,500.00 | £11,025.00 | £11,576.25 | £12,155.06 | £12,762.82 | £12,762.82 |
The costs and charges shown are for illustration purposes only based on the assumptions presented. Total HL charges and 5 year HL charges also include a £50 exit dealing charge. Figures may not add up to the given total due to rounding.
Ready to Invest?
Make sure you’ve read these key documents. They cover in more detail the risks and investment strategy of this VCT.